Results 281 to 290 of about 142,003 (296)

Thymidylate synthase protein expression in colorectalcancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil

Annals of Oncology, 2002
Sara Lonardi, Stefano Cascinu, P Giordani   +2 more
exaly  

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus

Annals of Oncology, 2005
Everett E Vokes, R H Ansari, A M Mauer
exaly  

Fluorouracil

Reactions Weekly
  +4 more sources

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

Cancer Treatment Reviews, 2013
Dorte L Nielsen, Anne Polk
exaly  

A phase III randomized trial of 5-fluorouracil, doxorubicin,and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

Annals of Oncology, 2002
Dae-Seog Heo, K U Lee, K H Jung
exaly  

Fluorouracil

Reactions Weekly, 1994
openaire   +1 more source

5-Fluorouracil—for disseminated breast cancer

Ca-A Cancer Journal for Clinicians, 1965
exaly  

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

Annals of Oncology, 2005
David Cunningham, Andrew R Norman, A R Norman   +2 more
exaly  

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

Annals of Oncology, 2009
David Cunningham, B Sirohi, P Koralewski
exaly  

DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report

Pharmaceutics, 2019
Richard Kim, Theodore J Wigle
exaly